P3 Health Partners Inc. (PIII)
NASDAQ: PIII · Real-Time Price · USD
8.85
+0.10 (1.17%)
Nov 3, 2025, 4:00 PM EST - Market closed
P3 Health Partners Revenue
P3 Health Partners had revenue of $355.79M in the quarter ending June 30, 2025, a decrease of -6.16%. This brings the company's revenue in the last twelve months to $1.46B, up 4.20% year-over-year. In the year 2024, P3 Health Partners had annual revenue of $1.50B with 18.48% growth.
Revenue (ttm)
$1.46B
Revenue Growth
+4.20%
P/S Ratio
0.02
Revenue / Employee
$4,060,619
Employees
360
Market Cap
63.63M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.50B | 234.08M | 18.48% |
| Dec 31, 2023 | 1.27B | 216.90M | 20.67% |
| Dec 31, 2022 | 1.05B | 412.11M | 64.66% |
| Dec 31, 2021 | 637.36M | 146.30M | 29.79% |
| Dec 31, 2020 | 491.06M | 345.58M | 237.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.11B |
PIII News
- 13 days ago - P3 Health Partners Schedules Third Quarter 2025 Earnings Release and Conference Call - Business Wire
- 6 weeks ago - P3 Health Partners to Participate in the Jefferies Healthcare Services Conference - Business Wire
- 2 months ago - Catalyst Solutions Announces Successful Launch of P3 Implementation Across Four States - PRNewsWire
- 2 months ago - P3 Health Partners Inc. (PIII) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - P3 Health Partners Announces Second Quarter 2025 Results - Business Wire
- 3 months ago - P3 Health Partners Schedules Second Quarter 2025 Earnings Release and Conference Call - Business Wire
- 3 months ago - Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc. - GlobeNewsWire
- 6 months ago - P3 Health Partners Inc. (PIII) Q1 2025 Earnings Call Transcript - Seeking Alpha